해부 병리학 시장 규모, 점유율, 성장 및 세계 산업 분석 : 유형별, 용도별, 지역별 인사이트와 예측(2026-2034년)

Growth Factors of anatomic pathology Market

The global anatomic pathology market is poised for substantial growth over the forecast period, driven by the increasing prevalence of chronic diseases and the rising demand for accurate disease diagnosis. The market was valued at USD 37.74 billion in 2025, projected to reach USD 40.29 billion in 2026, and is expected to grow to USD 74.04 billion by 2034, reflecting a CAGR of 7.90%. North America led the market in 2025 with a 36.18% share, attributed to advanced healthcare infrastructure, high test volumes, and widespread adoption of innovative pathology technologies.

Anatomic pathology, a specialty focusing on the diagnosis of diseases through the examination of tissues, organs, and bodily fluids, plays a critical role in cancer detection, inflammatory disease evaluation, and chronic condition management. According to the American Cancer Society (2025), approximately 2 million new cancer cases are estimated in the U.S., further bolstering the demand for anatomic pathology tests, including histopathology, immunohistochemistry, and molecular diagnostics.

Leading market players, such as Cardinal Health, F. Hoffmann-La Roche Ltd., and Leica Microsystems, are focusing on innovative instruments, consumables, and AI-enabled digital pathology solutions to address the growing patient population and demand for early disease detection.

Market Dynamics

Market Drivers

Increasing prevalence of chronic disorders such as cancer, autoimmune disorders, and inflammatory bowel diseases is driving the adoption of anatomic pathology products. According to the CDC (2024), inflammatory bowel disease affects 2.4-3.1 million people in the U.S. Moreover, advancements in early detection and screening, coupled with the integration of artificial intelligence (AI) and digital pathology, are increasing test volumes globally.

Other key growth drivers include:

• Shift toward precision medicine: Integration of biomarker testing with anatomic pathology enables personalized treatment decisions.
• Expanding healthcare infrastructure: Growth in hospitals, diagnostic centers, and laboratory modernization projects, particularly in Asia Pacific and Latin America, is increasing market penetration.
• Supportive reimbursement programs: Governments and insurers are expanding coverage for diagnostic tests, particularly for cancer screening.

Market Restraints

High costs associated with advanced products such as whole-slide imaging systems, microtomes, stainers, and tissue processing systems limit adoption, especially in small and mid-sized labs. Additional operational costs, slide preparation, and regulatory compliance further constrain product penetration.

Market Opportunities

The rising number of oncology-focused clinical trials is creating opportunities for manufacturers and laboratories to collaborate with contract research organizations. Biomarker assessment, tissue-based companion diagnostics, and histopathologic evaluation are increasingly critical in immunotherapy and gene therapy trials, boosting demand for advanced molecular and digital pathology platforms.

Market Challenges

• Limited diagnosis in developing countries: Delayed referrals, lack of skilled pathologists, and inadequate laboratory infrastructure hinder early detection.
• Regulatory barriers: Lengthy validation and approval processes for AI-based and molecular pathology solutions slow commercialization.
• Emergence of substitute technologies: Liquid biopsies and advanced imaging are starting to complement or replace traditional pathology methods.

Market Trends

Technological advancements such as AI, digital pathology, molecular diagnostics, and whole-slide imaging are transforming the market. According to the Mayo Clinic (2025), over 50% of surgical pathology cases were digitized and interpreted through digital platforms, enhancing diagnostic accuracy and workflow efficiency.

Segmentation Analysis

By Type

The market is segmented into products and services. Products, including instruments (microtomes, stainers, tissue processing systems) and consumables, dominated the market with a 63.13% share in 2026, driven by increasing anatomic pathology tests and regulatory approvals.

Example: In May 2024, Indica Labs received FDA approval for HALO AP Dx, a digital platform for primary diagnosis, strengthening its product portfolio.

By Application

• Disease diagnosis dominated with a 71.64% share in 2026, owing to the rising prevalence of chronic conditions such as cancer and autoimmune disorders.
• Drug discovery is projected to grow at a 7.7% CAGR.

By Technique

• Histopathology accounted for 45.62% share in 2026, driven by increasing chronic disease incidence.
• Molecular pathology is forecasted to grow at 8.3% CAGR, reflecting increasing adoption of advanced diagnostics.

By End User

• Hospitals & ASCs led the market with a 56.54% share in 2026, supported by the rising number of healthcare facilities and patient pool.
• Clinical laboratories are projected to grow at 7.7% CAGR.

Regional Outlook

• North America: Market valued at USD 13.65 billion in 2025, projected to USD 14.63 billion in 2026, with the U.S. accounting for USD 12.69 billion, driven by high test volumes and advanced infrastructure.
• Europe: Expected to reach USD 9.98 billion in 2026, supported by regulatory compliance, digital pathology adoption, and healthcare access.
• Asia Pacific: Estimated at USD 11.78 billion in 2026, with India at USD 2.4 billion and China at USD 3.62 billion.
• Latin America: Projected to reach USD 2.53 billion in 2026.
• Middle East & Africa: GCC expected at USD 0.37 billion in 2025.

Competitive Landscape

Key players include Cardinal Health, Hoffmann-La Roche Ltd., Avantor Inc., Danaher Corporation, SLMP LLC, Agilent Technologies, Indica Labs, and Hologic Inc. Strategic initiatives such as product launches, FDA approvals, acquisitions, and collaborations support market dominance.

Example: In June 2024, F. Hoffmann-La Roche Ltd. received FDA approval for the VENTANA DP 200 whole-slide imaging system, enhancing global product offerings.

Key Industry Developments

• September 2025: Labcorp implemented Roche's VENTANA DP 600 and DP 200 scanners.
• September 2025: StatLab Medical Products launched PiSmart S1 slide printer.
• July 2025: PathAI introduced its Precision Pathology Network (PPN), powered by AISight 1 IMS.
• March 2025: Techcyte launched Fusion SaaS platform for unified anatomic and clinical workflows.
• August 2024: StatLab acquired Diapath S.p.A. to strengthen its market presence.

Conclusion

The global anatomic pathology market is projected to grow from USD 37.74 billion in 2025 to USD 74.04 billion by 2034, at a CAGR of 7.90%, driven by increasing chronic disease prevalence, technological advancements, and expanding healthcare infrastructure. North America leads the market, while emerging regions present significant growth potential. Adoption of AI-enabled digital pathology, molecular diagnostics, and regulatory-approved instruments is expected to drive global market expansion, providing accurate, efficient, and personalized diagnostic solutions across the healthcare spectrum.

Segmentation By Type, Application, Technique, End User, and Region

By Type * Products

• Instruments
  • Microtomes
  • Tissue Processing Systems
  • Stainers
  • Others
• Consumables
• Services

By Application * Disease Diagnosis

• Drug Discovery
• Others

By Technique * Histopathology

• Immunohistochemistry (IHC)
• In-situ Hybridization
• Molecular Pathology
• Others

By End User * Hospitals & ASCs

• Specialty Clinics
• Clinical Laboratories
• Others

By Region * North America (By Type, By Application, By Technique, By End User, and by Country)

• U.S. (By Application)
• Canada (By Application)
• Europe (By Type, By Application, By Technique, By End User, and by Country/Sub-region)
  • U.K. (By Application)
  • Germany (By Application)
  • France (By Application)
  • Italy (By Application)
  • Spain (By Application)
  • Scandinavia (By Application)
  • Rest of Europe (By Application)
• Asia Pacific (By Type, By Application, By Technique, By End User, and by Country/Sub-region)
  • China (By Application)
  • Japan (By Application)
  • India (By Application)
  • Australia (By Application)
  • Southeast Asia (By Application)
  • Rest of Asia Pacific (By Application)
• Latin America (By Type, By Application, By Technique, By End User, and by Country/Sub-region)
  • Brazil (By Application)
  • Mexico (By Application)
  • Rest of Latin America (By Application)
• Middle East & Africa (By Type, By Application, By Technique, By End User, and by Country/Sub-region)
  • GCC (By Application)
  • South Africa (By Application)
  • Rest of the Middle East & Africa (By Application)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Prevalence of Key Disorders, Key Countries/Regions, 2025/2026
• 4.2. New Product Launches, Key Players
• 4.3. Key Industry Developments - Mergers, Acquisitions & Partnerships

5. Global Anatomic Pathology Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Type
  • 5.1.1. Products
    • 5.1.1.1. Instruments
      • 5.1.1.1.1. Microtomes
      • 5.1.1.1.2. Tissue Processing Systems
      • 5.1.1.1.3. Stainers
      • 5.1.1.1.4. Others
    • 5.1.1.2. Consumables
  • 5.1.2. Services
• 5.2. Market Analysis, Insights and Forecast - By Application
  • 5.2.1. Disease Diagnosis
  • 5.2.2. Drug Discovery
  • 5.2.3. Others
• 5.3. Market Analysis, Insights and Forecast - By Technique
  • 5.3.1. Histopathology
  • 5.3.2. Immunohistochemistry (IHC)
  • 5.3.3. In-situ Hybridization
  • 5.3.4. Molecular Pathology
  • 5.3.5. Others
• 5.4. Market Analysis, Insights and Forecast - By End User
  • 5.4.1. Hospitals & ASCs
  • 5.4.2. Specialty Clinics
  • 5.4.3. Clinical Laboratories
  • 5.4.4. Others
• 5.5. Market Analysis, Insights and Forecast - By Region
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa

6. North America Anatomic Pathology Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Type
  • 6.1.1. Products
    • 6.1.1.1. Instruments
      • 6.1.1.1.1. Microtomes
      • 6.1.1.1.2. Tissue Processing Systems
      • 6.1.1.1.3. Stainers
      • 6.1.1.1.4. Others
    • 6.1.1.2. Consumables
  • 6.1.2. Services
• 6.2. Market Analysis, Insights and Forecast - By Application
  • 6.2.1. Disease Diagnosis
  • 6.2.2. Drug Discovery
  • 6.2.3. Others
• 6.3. Market Analysis, Insights and Forecast - By Technique
  • 6.3.1. Histopathology
  • 6.3.2. Immunohistochemistry (IHC)
  • 6.3.3. In-situ Hybridization
  • 6.3.4. Molecular Pathology
  • 6.3.5. Others
• 6.4. Market Analysis, Insights and Forecast - By End User
  • 6.4.1. Hospitals & ASCs
  • 6.4.2. Specialty Clinics
  • 6.4.3. Clinical Laboratories
  • 6.4.4. Others
• 6.5. Market Analysis, Insights and Forecast - By Country
  • 6.5.1. U.S.
    • 6.5.1.1. By Application
  • 6.5.2. Canada
    • 6.5.2.1. By Application

7. Europe Anatomic Pathology Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Type
  • 7.1.1. Products
    • 7.1.1.1. Instruments
      • 7.1.1.1.1. Microtomes
      • 7.1.1.1.2. Tissue Processing Systems
      • 7.1.1.1.3. Stainers
      • 7.1.1.1.4. Others
    • 7.1.1.2. Consumables
  • 7.1.2. Services
• 7.2. Market Analysis, Insights and Forecast - By Application
  • 7.2.1. Disease Diagnosis
  • 7.2.2. Drug Discovery
  • 7.2.3. Others
• 7.3. Market Analysis, Insights and Forecast - By Technique
  • 7.3.1. Histopathology
  • 7.3.2. Immunohistochemistry (IHC)
  • 7.3.3. In-situ Hybridization
  • 7.3.4. Molecular Pathology
  • 7.3.5. Others
• 7.4. Market Analysis, Insights and Forecast - By End User
  • 7.4.1. Hospitals & ASCs
  • 7.4.2. Specialty Clinics
  • 7.4.3. Clinical Laboratories
  • 7.4.4. Others
• 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 7.5.1. U.K.
    • 7.5.1.1. By Application
  • 7.5.2. Germany
    • 7.5.2.1. By Application
  • 7.5.3. France
    • 7.5.3.1. By Application
  • 7.5.4. Spain
    • 7.5.4.1. By Application
  • 7.5.5. Italy
    • 7.5.5.1. By Application
  • 7.5.6. Scandinavia
    • 7.5.6.1. By Application
  • 7.5.7. Rest of Europe
    • 7.5.7.1. By Application

8. Asia Pacific Anatomic Pathology Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Type
  • 8.1.1. Products
    • 8.1.1.1. Instruments
      • 8.1.1.1.1. Microtomes
      • 8.1.1.1.2. Tissue Processing Systems
      • 8.1.1.1.3. Stainers
      • 8.1.1.1.4. Others
    • 8.1.1.2. Consumables
  • 8.1.2. Services
• 8.2. Market Analysis, Insights and Forecast - By Application
  • 8.2.1. Disease Diagnosis
  • 8.2.2. Drug Discovery
  • 8.2.3. Others
• 8.3. Market Analysis, Insights and Forecast - By Technique
  • 8.3.1. Histopathology
  • 8.3.2. Immunohistochemistry (IHC)
  • 8.3.3. In-situ Hybridization
  • 8.3.4. Molecular Pathology
  • 8.3.5. Others
• 8.4. Market Analysis, Insights and Forecast - By End User
  • 8.4.1. Hospitals & ASCs
  • 8.4.2. Specialty Clinics
  • 8.4.3. Clinical Laboratories
  • 8.4.4. Others
• 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 8.5.1. Japan
    • 8.5.1.1. By Application
  • 8.5.2. Australia
    • 8.5.2.1. By Application
  • 8.5.3. China
    • 8.5.3.1. By Application
  • 8.5.4. India
    • 8.5.4.1. By Application
  • 8.5.5. Southeast Asia
    • 8.5.5.1. By Application
  • 8.5.6. Rest of Asia Pacific
    • 8.5.6.1. By Application

9. Latin America Anatomic Pathology Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Type
  • 9.1.1. Products
    • 9.1.1.1. Instruments
      • 9.1.1.1.1. Microtomes
      • 9.1.1.1.2. Tissue Processing Systems
      • 9.1.1.1.3. Stainers
      • 9.1.1.1.4. Others
    • 9.1.1.2. Consumables
  • 9.1.2. Services
• 9.2. Market Analysis, Insights and Forecast - By Application
  • 9.2.1. Disease Diagnosis
  • 9.2.2. Drug Discovery
  • 9.2.3. Others
• 9.3. Market Analysis, Insights and Forecast - By Technique
  • 9.3.1. Histopathology
  • 9.3.2. Immunohistochemistry (IHC)
  • 9.3.3. In-situ Hybridization
  • 9.3.4. Molecular Pathology
  • 9.3.5. Others
• 9.4. Market Analysis, Insights and Forecast - By End User
  • 9.4.1. Hospitals & ASCs
  • 9.4.2. Specialty Clinics
  • 9.4.3. Clinical Laboratories
  • 9.4.4. Others
• 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 9.5.1. Brazil
    • 9.5.1.1. By Application
  • 9.5.2. Mexico
    • 9.5.2.1. By Application
  • 9.5.3. Rest of Latin America
    • 9.5.3.1. By Application

10. Middle East & Africa Anatomic Pathology Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Type
  • 10.1.1. Products
    • 10.1.1.1. Instruments
      • 10.1.1.1.1. Microtomes
      • 10.1.1.1.2. Tissue Processing Systems
      • 10.1.1.1.3. Stainers
      • 10.1.1.1.4. Others
    • 10.1.1.2. Consumables
  • 10.1.2. Services
• 10.2. Market Analysis, Insights and Forecast - By Application
  • 10.2.1. Disease Diagnosis
  • 10.2.2. Drug Discovery
  • 10.2.3. Others
• 10.3. Market Analysis, Insights and Forecast - By Technique
  • 10.3.1. Histopathology
  • 10.3.2. Immunohistochemistry (IHC)
  • 10.3.3. In-situ Hybridization
  • 10.3.4. Molecular Pathology
  • 10.3.5. Others
• 10.4. Market Analysis, Insights and Forecast - By End User
  • 10.4.1. Hospitals & ASCs
  • 10.4.2. Specialty Clinics
  • 10.4.3. Clinical Laboratories
  • 10.4.4. Others
• 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 10.5.1. GCC
    • 10.5.1.1. By Application
  • 10.5.2. South Africa
    • 10.5.2.1. By Application
  • 10.5.3. Rest of Middle East & Africa
    • 10.5.3.1. By Application

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability))
  • 11.2.1. Cardinal Health
  • 11.2.2. F. Hoffmann La. Roche Ltd.
  • 11.2.3. Avantor, Inc.
  • 11.2.4. Danaher Corporation
  • 11.2.5. SLMP, LLC.
  • 11.2.6. Agilent Technologies, Inc.
  • 11.2.7. Indica Labs, LLC.
  • 11.2.8. Hologic, Inc.